04:37 PM EDT, 03/26/2024 (MT Newswires) -- Jeff E. Knight, Chief Operating Officer, on March 22, 2024, sold 32,359 shares in Crinetics Pharmaceuticals ( CRNX ) for $1,433,675. Following the Form 4 filing with the SEC, Knight has control over a total of 52,580 shares of the company, with 52,580 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1658247/000120919124005081/xslF345X03/doc4.xml